Your trusted source for investing success

Tag: medical device

Obalon Therapeutics Prices Public Offering of Common Stock

Obalon Therapeutics (NASDAQ:OBLN), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announced the pricing of an underwritten public offering of 5,454,545 shares of its common stock at a public offering price of $5.50 per share.

As quoted

NeuroMetrix and GlaxoSmithKline will Collaborate to Develop and Expand Access to Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq:NURO) announced today a collaboration with GlaxoSmithKline (NYSE:GSK), one of the world’s largest science-led global healthcare companies, involving Quell® Wearable Pain Relief Technology™.

As quoted in the press release:
“We are excited by the opportunity to partner with GSK Consumer Healthcare to expand access to Quell technology among chronic pain sufferers around

Lexington Completes IRB Submission in Preparation for Clinical Study

Lexington Biosciences (CSE:LNB), a development-stage medical device company, is pleased to announce it has completed its requisite documentation and submitted an application for Institutional Review Board approval of its pilot clinical study.

As quoted in the press release:
In preparation for commercialization of the HeartSentry device, the pathway for regulatory approval includes

Imagin Medical Recruits Senior Healthcare Industry CFO

Imagin Medical (CSE:IME) announced they hired John Vacha as the Company’s new CFO. He is a licensed CPA in Massachusetts, holds a MBA and a MS in Accounting from Northeastern University in Boston and has 20 years’ experience in the healthcare industry.

As quoted in the press release:
John also served as

Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations

Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has partnered with Mr. Charles (Chuck) Austin and JK Advisors in order to scale up operational

BioSig Technologies Completes Private Placement

BioSig Technologies Completes Private Placement

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company closed a private placement with proceeds of $4,512,901.

The Company issued 3,008,607 common shares at a

4 Small Medical Device Companies to Watch

4 Small Medical Device Companies to Watch

Now that 2017 is behind us, the INN takes a closer look at some medical device companies with interesting paths ahead of them in 2018–be it from upcoming trials, recent approvals or potential developments on the horizon.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Big News Roundup: Telferscot and Canntab Therapeutics Execute Definitive Agreement; Phivida Launches Nano-CBD™ Iced Tea Product Line

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/big-news-roundup-lifescience/